2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Hyponatremia: new trials by email Literature Review of Hyponatremia trials Research Report on Hyponatremia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Urea for Chronic Hyponatremia Urea - Hyponatremia, Inappropriate ADH Syndrome | Phase 2 | Terminated | Helbert Rondon Berrios, MD, MS | 2 | 2021-12-28 | 2024-05-20 |
| Tolvaptan for In-hospital Hyponatremia Tolvaptan, Standard therapy - Hyponatremia | Phase 2 | Terminated | Mario Negri Institute for Pharmacological Research | 3 | 2011-06-01 | 2016-12-15 |
Inappropriate ADH Syndrome (2) · Diabetes Insipidus (1)
Brain Diseases (2) · Central Nervous System Diseases (2) · Endocrine System Diseases (2) · Hypothalamic Diseases (2) · Metabolic Diseases (2) · Nervous System Diseases (2) · Nutritional and Metabolic Diseases (2) · Pituitary Diseases (2) · Water-Electrolyte Imbalance (2) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Kidney Diseases (1) · Male Urogenital Diseases (1) · Urogenital Diseases (1) · Urologic Diseases (1)
Standard of Care (1) · Tolvaptan (1) · Urea (1)
Helbert Rondon Berrios, MD, MS (1) · Mario Negri Institute for Pharmacological Research (1)
Italy (1) · United States (1)
Helbert Rondon Berrios, MD. MS (1)
R21DK122023 (1)